Short answer
Cardiff Oncology, Inc. (CRDF) filed an 8-K current report with the SEC on June 11, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All six director nominees elected through 2027, with zero opposing votes for each nominee.
Cardiff Oncology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All six director nominees elected through 2027, with zero opposing votes for each nominee
- BDO USA, P.C. auditor appointment ratified, receiving 40,239,508 affirmative votes
- Equity plan expanded to 15,150,000 issuable shares, increasing potential shareholder dilution
- Executive compensation approved by 17,120,176 votes, supporting current pay practices
- 41,614,848 shares represented, establishing a valid quorum at the June 11, 2026 meeting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardiff Oncology, Inc. 8-K filings
Get the next CRDF 8-K as it lands
Follow CRDF for push alerts, or ask the research agent what this filing means.